Month: December 2019

Intellipharmaceutics Announces FDA Advisory Committee Meeting for Aximris XR(TM) (Oxycodone Hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain

TORONTO, ON / ACCESSWIRE / December 5, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a...

MiOXSYS Male Infertility Test Will be Featured in Product Symposium at the 8th Annual Congress of the German Federation of Reproductive Biology and Medicine

ENGLEWOOD, CO / ACCESSWIRE / December 5, 2019 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing...

CORRECTING and REPLACING Nearly a Quarter of a Million Prescribers Using Surescripts Prescription Price Transparency Tool to View Patient Medication Cost Information

Washington, D.C., Leads the Nation with Nearly 50% of E-Prescribers Utilizing the Technology ARLINGTON, Va.--(BUSINESS WIRE)--#EHR--Eighth paragraph, fourth sentence of...

MediOrbis™ Broadens Global Reach, Telemedicine Access to Specialty Physicians: Expands Co-Branded Digital, Telehealth & Technology Platform with MediGuide Second Medical Opinion

CLEVELAND--(BUSINESS WIRE)--MediOrbis, a multi-specialty telemedicine and telehealth company with a first-of-its-kind chronic disease management (CDM) program, announces expanded access to...

error: Content is protected !!